Asthma affects nearly 300 million people worldwide, and 24.6 million Americans had asthma in 2009. In severe forms, asthma can be deadly; however asthma-related deaths have been decreasing thanks to medical advances.
Jul 20, 2011
0
0
(Medical Xpress)—Two surprising risk factors – diminished lung function and low serum potassium levels - appear to have nearly the same impact as obesity in explaining why African-Americans are disproportionately prone ...
Feb 6, 2014
0
0
A large new Northwestern Medicine study upends our understanding of vitamin E and ties the increasing consumption of supposedly healthy vitamin E-rich oils—canola, soybean and corn – to the rising incidence of lung inflammation ...
May 20, 2014
0
0
A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary ...
May 20, 2012
0
0
Scientists at the University of North Carolina at Chapel Hill are testing a new route for remdesivir, a pill form of the COVID-19 treatment that's given to half of all hospitalized patients with the disease.
Mar 22, 2022
0
79
The first randomized controlled trial to compare two lung volume reduction procedures for people with emphysema has found that both lead to similar improvements in lung function, breathlessness and exercise capacity.
Sep 6, 2022
0
7
Vitamin C supplementation in pregnant women who are unable to quit smoking significantly improves pulmonary function in their newborns, according to a new study.
May 22, 2012
0
0
(HealthDay)—A pair of drugs offers new hope to patients with a progressive, fatal disease that robs their breath by scarring the lungs, according to clinical trial results.
May 18, 2014
0
0
Three-quarters of chronic obstructive pulmonary disease (COPD) cases have their origins in poor lung function pathways beginning in childhood. These pathways are associated with exposures in childhood, and amplified by factors ...
Apr 6, 2018
0
18
St. Jude Children's Research Hospital scientists have identified fibroblasts as the cells that serve as the gatekeeper of the inflammatory immune response in the lungs following influenza and other respiratory infections. ...
Oct 29, 2020
0
30
